Latest Cancer News

Oncotype DX® Predicts Recurrence Risk in Node-negative and Node-positive Breast Cancer Treated with Tamoxifen or Arimidex (03/09/2010)
Among postmenopausal women with early, hormone receptor-positive breast cancer treated with either tamoxifen (Nolvadex®) or Arimidex® (anastrozole), the Oncotype DX test predicts the risk of distant cancer recurrence in both node-negative and node-positive patients

Addition of Hormone Therapy to Radiation Improves Survival in Intermediate-risk, Early-stage Prostate Cancer (03/09/2010)
Short-term hormone therapy delivered before and during moderate-dose radiation therapy improves survival and reduces risk of recurrence compared with radiation alone in men with intermediate-risk, early-stage prostate cancer

Cystoscopy Alone Is the Most Cost-effective Way to Monitor for Recurrence of Bladder Cancer (03/09/2010)
The addition of a urine test to standard cystoscopy screening in order to monitor for bladder cancer recurrence unnecessarily increases the cost of monitoring as well as the risk for a false-positive result and does not improve tumor detection, according to the results of a study presented at the 2010 Genitourinary Cancers Symposium in San Francisco

More Cancer News

Ubicaciones

Glendale, AZ
5601 W. Eugie Ave.
Suite 106
Glendale, Arizona 85304
phone: (602) 978-6255
Scottsdale, AZ
10460 N. 92nd Street
Suite 402
Scottsdale, Arizona 85258 phone: (480) 941-1211
Avondale, AZ
10320 W. McDowell Road
Suite N1444
Avondale, Arizona 85323
phone: (623) 478-8091